Tate & Lyle PLC Transaction in Own Shares
21 June 2024 - 3:03AM
RNS Regulatory News
RNS Number : 2943T
Tate & Lyle PLC
20 June 2024
|
|
|
Transactions in Own Securities
|
|
|
|
|
20 June 2024
|
|
|
|
Tate & Lyle plc (the
"Company") announces that
it has purchased the following number of its ordinary shares from
Merrill Lynch International ("BofA") as part of its share buyback
programme announced on 20 June 2024 (the "Programme").
|
|
|
|
|
|
|
|
|
Date of purchase:
|
20 June 2024
|
|
|
Number of ordinary shares of
£0.2916666667 each purchased:
|
231,599
|
|
|
Highest price paid per share
(£):
|
6.67
|
|
|
Lowest price paid per share (£)
:
|
5.99
|
|
|
Volume weighted average price paid
per share (£):
|
6.25
|
|
|
|
|
|
|
|
|
The repurchased shares will be held
in treasury. Following the purchase of these shares, the Company
holds 231,599 of its ordinary shares in treasury and has
401,478,660 ordinary shares in issue (excluding treasury
shares).
|
|
|
|
|
|
|
|
|
Aggregated Information
|
|
|
|
|
|
|
|
|
|
|
Date
|
Trading venue
|
Volume weighted average price (£ per share)
|
Number of Shares Purchased
|
|
|
20 June 2024
|
London Stock Exchange
|
6.27
|
136,400
|
|
|
20 June 2024
|
Chi-X (CXE)
|
6.21
|
37,000
|
|
|
20 June 2024
|
BATS (BXE)
|
6.22
|
58,199
|
|
|
|
|
|
|
|
|
Transaction Details
|
|
|
|
|
|
|
|
|
|
|
In accordance with Article 5(1)(b)
of the Market Abuse Regulation (EU) No 596/2014 as it forms part of
UK law, a full breakdown of the individual trades made by BofA on
behalf of the Company as part of the Programme is detailed on the
attached http://www.rns-pdf.londonstockexchange.com/rns/2943T_1-2024-6-20.pdf
|
|
|
|
|
|
|
|
|
The LEI reference for Tate &
Lyle PLC is 2138008K14474WPKZ244.
|
|
|
|
|
|
|
|
|
|
For further information please
contact:
|
|
|
|
|
|
|
|
|
|
|
Christopher Marsh, VP, Investor
Relations
|
|
|
Mobile: +44 (0)7796 192
688
|
|
|
|
|
|
|
|
|
Nick Hasell (FTI Consulting), Media
Relations
|
|
|
Mobile: +44 (0)7825 523
383
|
|
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
POSFMMRTMTMTBBI
Tate & Lyle (LSE:TATE)
Historical Stock Chart
From May 2024 to Jun 2024
Tate & Lyle (LSE:TATE)
Historical Stock Chart
From Jun 2023 to Jun 2024
